#Pharmaceutical Packaging Market Share

[delvens-blog]

The global market for Pharmaceutical Packaging is expected to reach $122.6 billion by 2030 from $109.4 billion in 2022, registering impressive expansion at a compound annual growth rate (CAGR) of 6.7%. Some of the major players are Amcor Ltd., Becton, Dickinson, Aptargroup, Inc., Capsugel Inc., Gerresheimer AG, Schott AG, Terumo Corporation, WEST Pharmaceutical Services, Inc., Berry Plastics Group, Inc., Westrock Company, SGD SA, Comar LLC, International Paper Company, Owens Illinois Inc., Aptar Group Inc.

[rkingresearch]

Pharmaceutical Packaging Market Size, Value, Report 2022-2028

The Global Pharmaceutical Packaging Market Size was valued at USD 90.2 billion in 2021. The market is projected to grow by USD 144.2 billion in 2028, at a CAGR of 8.9%.

The global Pharmaceutical Packaging market research gives a detailed and practical analysis of the products and services in this market which provides a competitive advantage to the existing and new businesses. In depth study and overview of the market has been collected by the overall insight of the industry and specifies the market segmentation, potential opportunities, growing market trends and events, current and future advancements, and other elements. This report will also showcase many possibilities of upscaling the global Pharmaceutical Packaging market share size.

Get a Sample PDF of Report - https://www.extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/pharmaceutical-packaging-market/21601

The competitive landscape of Pharmaceutical Packaging market includes major players such as:

 The report includes all key points related to the most important determinants of Pharmaceutical Packaging industry’s growth. This research looks closely at the market competition, product development trends, and sale prospects such as evolutions of consumer behavior, current market need, client preferences, and changing needs and demand. Furthermore, the report discusses its prominent players, along with their new entrants, influential players and much more.

The Pharmaceutical Packaging market analysis will help companies identify potential development areas and create strategies to take advantage of emerging opportunities. It analyzes the current competitive environment in addition to offering key details like market statistics and product releases from leading companies in this industry. This industry is characterized in terms of market size, market coverage, market exchange rate, segmentation, and market share.

Inquire Before Buying This Research Report: https://www.extrapolate.com/enquire/Healthcare-Medical-Devices-Biotechnology/pharmaceutical-packaging-market/21601

The Pharmaceutical Packaging market is segmented by types into:

SEGMENTATION:-

 By Material

  By Product Type

 By Drug Delivery

 By Packaging Type

By Region

 Detailed analysis of applications and customers that use the services provided by the Pharmaceutical Packaging market is also discussed in the report. Similarly, it provides information about its key competitors and their footprints according to the respective regions. Along with it, the study will cover company portfolios, Pharmaceutical Packaging market growth opportunities, obstacles, collaborations, mergers and acquisitions.

Moreover, it provides a quick summary of the Pharmaceutical Packaging global market developments for the estimated period of time which will ultimately provide ideas to businesses in terms of working and processes of the Pharmaceutical Packaging market. This research has been generated based on the historical data and future possibilities of the market. The overall industry scale of the market has been studied from the global perspective by utilizing multiple research methodologies such as Porter’s five forces model, SWOT and PESTEL analysis.

Detailed TOC of Global Pharmaceutical Packaging Market @ https://www.extrapolate.com/toc/Healthcare-Medical-Devices-Biotechnology/pharmaceutical-packaging-market/21601

TABLE OF CONTENTS:-

1. Executive Summary

2. Research Methodology

3. Market Outlook

4. COVID-19 Impact On Pharmaceutical Packaging Market

5. Global Pharmaceutical Packaging Market Overview, By Material, 2015 - 2028(USD Million)

6. Global Pharmaceutical Packaging Market Overview, By Product Type, 2015 - 2028(USD Million)

7. Global Pharmaceutical Packaging Market Overview, By Drug Delivery, 2015 - 2028(USD Million)

8. Global Pharmaceutical Packaging Market Overview, By Packaging Type, 2015 - 2028(USD Million)

9. Global Pharmaceutical Packaging Market Overview, By Geography, 2015 - 2028(USD Million)

10. North America Pharmaceutical Packaging Market Overview, By Countries, 2015 - 2028(USD Million)

About Us

Extrapolate is a global market research and content services firm that works closely with clients in various industries to improve market position, increase returns on marketing investments, and define and implement strategies that get real results.

In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets-not merely respond to them. Extrapolate helps clients develop market perspectives that drive commercial success.

Contact Us:

Extrapolate Phone: (+1) 888 328 2189 E-mail: talk@extrapolate.com Website: https://www.extrapolate.com

[industrynewsupdates]

Pharmaceutical Packaging Market Trends, Opportunities, and Challenges 2024 - 2030

The global pharmaceutical packaging market was valued at USD 139.37 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030. A key driver of this growth is the substantial expansion of the pharmaceutical sector itself. In recent years, the pharmaceutical industry has experienced rapid growth, fueled by continuous advancements in science and technology. This upward trend is expected to persist throughout the forecast period, especially in developing countries such as China, India, Saudi Arabia, and Brazil, where the healthcare infrastructure and pharmaceutical demand are expanding quickly.

The United States is the largest pharmaceutical market in the world. Several factors contribute to this dominance, including the size of the healthcare system, high per capita income, and substantial investments in drug development within the country. These elements collectively drive the growth of the pharmaceutical sector in the U.S. Additionally, the increasing importance of generic drugs and broader access to better healthcare services are expected to create further growth opportunities for pharmaceutical packaging in the coming years.

A significant piece of legislation, the 21st Century Cures Act, was signed into law in the U.S. on December 13, 2016. This act is designed to expedite the development of medical products, including pharmaceutical drugs, by enhancing the approval process and encouraging innovation in the industry. The implementation of the Cures Act is expected to spur new developments in pharmaceutical products, which will, in turn, drive the demand for pharmaceutical packaging in the U.S. market. These factors collectively indicate a continued growth trajectory for the pharmaceutical packaging industry, especially in key markets such as the U.S.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

Regional Insights

North America

North America dominated the pharmaceutical packaging market with a revenue share of 35.9% in 2023. The largest end-use segment in the region was pharma manufacturing, which includes in-house production of pharmaceutical products. The presence of a substantial number of pharmaceutical plastic bottle manufacturers in the U.S., such as AptarGroup Inc., Gerresheimer AG, Amcor Ltd., and Berry Plastics Group, Inc., is expected to have a positive impact on the demand for pharmaceutical plastic bottles over the forecast period. These companies play a critical role in supplying the packaging materials required for pharmaceutical products, further driving market growth.

Asia Pacific

The Asia Pacific region is anticipated to register the fastest CAGR of over 12% from 2024 to 2030. This growth is driven by increasing health awareness among consumers, particularly in developing countries such as China and India, and rising disposable income levels. As a result, the demand for pharmaceuticals is expected to grow, which will in turn boost the need for pharmaceutical packaging solutions. In 2020, China led the Asia Pacific market and is expected to maintain this position due to government initiatives like Healthy China 2020, as well as a growing aging population and expanding contract-manufacturing activities. These factors contribute to the increasing demand for pharmaceutical packaging in the region.

Europe

In Europe, the pharmaceutical packaging market is expected to experience significant growth due to rising research and development (R&D) activities and the continuous introduction of new medicines aimed at improving patient health and quality of life. Companies such as BioNTech SE and CureVac in Europe have made notable achievements, particularly with their successful vaccine development in 2020. These successes have attracted further investments into the biotech industry in countries like Germany, Russia, and the U.K., propelling the growth of pharmaceutical packaging in the region.

The Saudi Arabian pharmaceutical packaging market is one of the major players in the Middle East & Africa region. International pharmaceutical companies are recognizing the potential of the Middle Eastern and North African (MENA) market. For example, Sanofi is a leading player in Morocco, and GlaxoSmithKline leads the market in Saudi Arabia. In addition, local pharmaceutical companies such as SPIMACO and Hikma from Jordan and Saudi Arabia are aiming to become regional leaders. These developments are expected to drive the demand for various pharmaceutical packaging materials in the region during the forecast period.

Browse through Grand View Research's Plastics, Polymers & Resins Industry Research Reports.

• The global flexible paper packaging market size was estimated at USD 50.35 billion in 2023 and is projected to grow at a CAGR of 4.2% from 2024 to 2030. 

• The global seaweed packaging market size was valued at USD 699.23 million in 2023 and is expected to expand at a CAGR of 6.6% from 2024 to 2030.

Key Companies & Market Share Insights

The global pharmaceutical packaging market is highly competitive, with numerous players competing for market share. To strengthen their positions, key players are increasingly focusing on acquisitions, which is intensifying the competition within the market. These companies directly compete with each other to secure contracts from large pharmaceutical manufacturers. As a result, the level of competitive rivalry in the market is high.

To differentiate themselves in this competitive landscape, companies are focusing on offering value-added services to attract more clients. Common processes employed by packaging manufacturers to enhance their offerings include spray painting, ultraviolet (UV) coating, and metallization to color packaging containers. Additionally, packaging companies are incorporating various anti-counterfeit measures, such as barcodes, holograms, sealing tapes, and radio frequency identification (RFID) technologies to ensure product authenticity and security.

Notable developments in the market include:

• In November 2023, Amcor Plc, a leading global provider of packaging solutions, announced a Memorandum of Understanding (MOU) with NOVA Chemicals Corporate, a producer of sustainable polyethylene. Under the agreement, Amcor will procure mechanically recycled polyethylene resin (rPE) from NOVA Chemicals for use in the production of flexible packaging films. This partnership supports Amcor’s commitment to sustainable packaging by increasing the use of recycled materials, contributing to the circularity of packaging.

• In July 2023, Constantia Flexibles introduced a new pharmaceutical packaging solution called REGULA CIRC, which uses coldform foil. The packaging replaces conventional PVC with a PE sealing layer, resulting in reduced plastic content and a higher proportion of aluminum. This shift not only enhances the sustainability of the packaging but also improves material recovery during the recycling process.

• In April 2023, Südpack launched its PharmaGuard blister, a new polypropylene-based blister packaging. This product is designed to offer an exceptional water vapor barrier and effective resistance to UV light and oxygen, making it suitable for the packaging of sensitive pharmaceutical products that require enhanced protection.

Key Pharmaceutical Packaging Companies:

• Amcor plc

• Becton, Dickinson, and Company

• AptarGroup, Inc.

• Drug Plastics Group

• Gerresheimer AG

• Schott AG

• Owens Illinois, Inc.

• West Pharmaceutical Services, Inc.

• Berry Global, Inc.

• WestRock Company

• SGD Pharma

• International Paper

• Comar, LLC

• CCL Industries, Inc.

• Vetter Pharma International

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[marketanalysisdata]

Pharmaceutical Packaging Market Analysis Report - Industry Trends, Growth and Segmentation 2030

In 2023, the global pharmaceutical packaging market reached a valuation of USD 139.37 billion and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2030. This growth is largely driven by the rapid expansion of the pharmaceutical industry, which has seen significant advancements in science and technology in recent years. These advancements are anticipated to continue driving demand, especially in emerging markets like China, India, Saudi Arabia, and Brazil, where pharmaceutical production and healthcare services are expanding rapidly.

The United States holds the largest pharmaceutical market share worldwide. Key factors behind this include the nation’s extensive healthcare infrastructure, high per capita income, and significant investments in drug research and development. The rise in generic drugs and improved access to healthcare services in the U.S. are also expected to create promising opportunities for pharmaceutical packaging over the coming years. Additionally, the 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, was enacted to accelerate the development and approval of medical products, encouraging innovations that are anticipated to drive demand for pharmaceutical packaging in the U.S.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

In Europe, the pharmaceutical industry is a crucial component of the economy and is one of the region's most high-performing and technologically advanced sectors. Recent years have seen a significant shift toward the development of biopharmaceutical drugs, a focus that has grown substantially. Biopharmaceuticals often require specialized packaging, as many biotechnology-derived drug therapies are unstable in liquid form and are instead offered as lyophilized (freeze-dried) or dry powder formulations. These specialized dosage forms demand advanced packaging solutions to maintain the drugs' stability and efficacy, creating new opportunities for packaging manufacturers to innovate.

The pharmaceutical packaging market is diverse and fragmented, featuring large and medium-sized international companies alongside smaller domestic players. Key players in this market include Amcor plc, Becton, Dickinson and Company, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, O-I Glass, Inc., SGD Pharma, West Pharmaceutical Services, Inc., Berry Global Group, Inc., WestRock Company, International Paper, Comar, LLC, CCL Industries, and Vetter Pharma International.

Product Segmentation Insights:

Pharmaceutical packaging is categorized into three main types: primary, secondary, and tertiary packaging. In 2023, primary packaging accounted for the largest share of the market. Primary packaging refers to materials such as bottles, tubes, and blister packs that come into direct contact with the drug, protecting it from contamination and aiding in safe storage. Primary packaging often also plays a role in dispensing and dosing, and manufacturers are focusing on user-friendly designs, including easy-open closures and dispensing systems that ensure the correct dose is given at the appropriate time. These advancements are especially beneficial for elderly populations, who may need additional support in handling medication.

Secondary pharmaceutical packaging is the next layer of protection, grouping multiple primary packages to safeguard them from external impacts. This packaging is critical for both branding and logistics. It not only helps protect the drug but also serves as a marketing tool by displaying the product in an attractive way. Secondary packaging also makes it easier to handle and transport multiple units, which is important for distribution efficiency.

Tertiary packaging, on the other hand, is used to wrap or bundle large groups of products, facilitating safe handling and transportation of goods across long distances. Examples of tertiary packaging include brown cardboard boxes, shrink wraps, and plastic bags. The growth of e-pharmacy (online pharmaceutical sales) has contributed to the increased need for tertiary packaging, as it ensures the safe and efficient transport of pharmaceutical products directly to consumers. This trend is expected to further drive demand for tertiary packaging over the forecast period.

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Pharmaceutical Packaging Market Overview, Challenges and Growth Opportunities Analysis till 2030

In 2023, the global pharmaceutical packaging market reached a valuation of USD 139.37 billion and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2030. This growth is largely driven by the rapid expansion of the pharmaceutical industry, which has seen significant advancements in science and technology in recent years. These advancements are anticipated to continue driving demand, especially in emerging markets like China, India, Saudi Arabia, and Brazil, where pharmaceutical production and healthcare services are expanding rapidly.

The United States holds the largest pharmaceutical market share worldwide. Key factors behind this include the nation’s extensive healthcare infrastructure, high per capita income, and significant investments in drug research and development. The rise in generic drugs and improved access to healthcare services in the U.S. are also expected to create promising opportunities for pharmaceutical packaging over the coming years. Additionally, the 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, was enacted to accelerate the development and approval of medical products, encouraging innovations that are anticipated to drive demand for pharmaceutical packaging in the U.S.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

In Europe, the pharmaceutical industry is a crucial component of the economy and is one of the region's most high-performing and technologically advanced sectors. Recent years have seen a significant shift toward the development of biopharmaceutical drugs, a focus that has grown substantially. Biopharmaceuticals often require specialized packaging, as many biotechnology-derived drug therapies are unstable in liquid form and are instead offered as lyophilized (freeze-dried) or dry powder formulations. These specialized dosage forms demand advanced packaging solutions to maintain the drugs' stability and efficacy, creating new opportunities for packaging manufacturers to innovate.

The pharmaceutical packaging market is diverse and fragmented, featuring large and medium-sized international companies alongside smaller domestic players. Key players in this market include Amcor plc, Becton, Dickinson and Company, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, O-I Glass, Inc., SGD Pharma, West Pharmaceutical Services, Inc., Berry Global Group, Inc., WestRock Company, International Paper, Comar, LLC, CCL Industries, and Vetter Pharma International.

Product Segmentation Insights:

Pharmaceutical packaging is categorized into three main types: primary, secondary, and tertiary packaging. In 2023, primary packaging accounted for the largest share of the market. Primary packaging refers to materials such as bottles, tubes, and blister packs that come into direct contact with the drug, protecting it from contamination and aiding in safe storage. Primary packaging often also plays a role in dispensing and dosing, and manufacturers are focusing on user-friendly designs, including easy-open closures and dispensing systems that ensure the correct dose is given at the appropriate time. These advancements are especially beneficial for elderly populations, who may need additional support in handling medication.

Secondary pharmaceutical packaging is the next layer of protection, grouping multiple primary packages to safeguard them from external impacts. This packaging is critical for both branding and logistics. It not only helps protect the drug but also serves as a marketing tool by displaying the product in an attractive way. Secondary packaging also makes it easier to handle and transport multiple units, which is important for distribution efficiency.

Tertiary packaging, on the other hand, is used to wrap or bundle large groups of products, facilitating safe handling and transportation of goods across long distances. Examples of tertiary packaging include brown cardboard boxes, shrink wraps, and plastic bags. The growth of e-pharmacy (online pharmaceutical sales) has contributed to the increased need for tertiary packaging, as it ensures the safe and efficient transport of pharmaceutical products directly to consumers. This trend is expected to further drive demand for tertiary packaging over the forecast period.

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[mordorintelligencemarketresearch]

The Growing Demand for Pharmaceutical Glass Packaging: Market Insights and Future Outlook

Market Overview:

The pharmaceutical glass packaging market is projected to be valued at USD 29.77 billion in 2024 and is expected to grow to USD 38.52 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.29% during the forecast period from 2024 to 2029.

Key Trends:

Increasing Demand for Biopharmaceuticals: The rise of biologic drugs and vaccines is fueling the demand for high-quality, sterile glass packaging. These drugs require secure and contamination-free packaging, which glass containers can provide due to their superior barrier properties.

Sustainability Initiatives: Glass is considered a sustainable packaging material due to its recyclability. As the pharmaceutical industry focuses more on sustainability, the demand for glass packaging, especially recyclable glass, is increasing.

Technological Innovations in Glass Manufacturing: The industry is witnessing advancements in glass-making technologies, improving the strength, durability, and design of pharmaceutical glass containers. These innovations are aimed at enhancing product protection and safety.

Rising Healthcare Expenditures: With global healthcare spending on the rise, particularly in emerging economies, the demand for pharmaceutical products, and by extension, pharmaceutical packaging, is expected to grow. This provides an opportunity for the glass packaging industry to expand.

Preference for Single-Use Glass Packaging: With a growing focus on hygiene and product safety, there is a shift toward single-use glass packaging solutions in the pharmaceutical sector. This is especially relevant in injectable drugs, where contamination prevention is paramount.

Challenges:

High Cost of Glass Packaging: The production cost of glass packaging is higher compared to other materials like plastic. This can limit its widespread adoption, especially in cost-sensitive markets.

Fragility and Risk of Breakage: Glass, while durable in terms of preserving product integrity, is more fragile than other packaging materials. This increases the risk of breakage during transportation, potentially leading to product loss and increased packaging costs.

Regulatory Compliance: Pharmaceutical glass packaging must comply with stringent regulatory standards, such as FDA requirements. Keeping up with these regulations can be challenging for manufacturers, especially those operating in multiple regions with different compliance standards.

Supply Chain Disruptions: The glass packaging industry is often impacted by raw material shortages and supply chain disruptions. These challenges, such as the availability of high-quality glass and labor shortages, can affect production timelines and costs.

Conclusion:

The pharmaceutical glass packaging market is poised for significant growth driven by the increasing demand for biologics, advancements in packaging technology, and a global push for more sustainable practices. Despite challenges like high production costs and fragility, the industry is innovating to meet the evolving needs of the pharmaceutical sector. As the market grows, manufacturers must focus on overcoming these hurdles while capitalizing on emerging trends to remain competitive in a rapidly evolving environment.

[marketresreasrch]

Pharmaceutical Contract Packaging Market: Industry Insights and Future Projections for 2022–2030

Pharmaceutical Contract Packaging Market Overview

The global Pharmaceutical Contract Packaging Market Size was valued at USD 13.02 Billion in 2021 and is projected to reach from USD XX Billion billion in 2022 to USD 31.21 Billion by 2030, growing at a CAGR of 10.2% during the forecast period.

Get a Free Sample Research Report: https://straitsresearch.com/report/pharmaceutical-contract-packaging-market/request-sample 

Pharmaceutical Contract Packaging Market Report Scope and Research Methodology

The scope of this report encompasses a comprehensive analysis of Pharmaceutical Contract Packaging Market, focusing on the key trends, challenges, and opportunities that are shaping its future. Through a combination of primary and secondary research methodologies, this study incorporates data gathered from industry experts, market surveys, and relevant academic sources. A detailed examination of both qualitative and quantitative data has been conducted to ensure a well-rounded understanding of the subject. The research methodology involved extensive market analysis, expert interviews, and the review of relevant literature, ensuring the report delivers valuable insights for stakeholders looking to stay ahead in the Pharmaceutical Contract Packaging Market .

To buy the research report : https://straitsresearch.com/buy-now/pharmaceutical-contract-packaging-market 

Pharmaceutical Contract Packaging Market Regional Insights

The Pharmaceutical Contract Packaging Market  report provides in-depth regional insights, highlighting key developments, market dynamics, and growth opportunities across various geographic areas. It examines how regional factors such as economic conditions, consumer behavior, regulatory changes, and technological advancements are influencing market trends. By offering a comprehensive breakdown of each region’s performance, the study enables stakeholders to understand regional variations and identify areas with the highest potential for growth. This detailed analysis serves as a strategic guide for businesses and investors seeking to optimize their approach to regional markets and make informed decisions for future expansion.

Pharmaceutical Contract Packaging Market Segmentation

By Service

Primary

Secondary

Tertiary

Pharmaceutical Contract Packaging Market Key Players

Ropack Inc

Sharp (UDG Healthcare)

Reed-Lane Inc

PCI Pharma Services

UNICEP Packaging LLC MPH Co-Packing

Tjaopak

SternMaid GmbH

Variopack Lohnfertigungen GmbH

CentralPharma

Tripak Pharmaceuticals

Jam Jams

Asiapack Limited (Elanders Group)

Finishing Services.

Browse Detailed Summary of Research Report with TOC: https://straitsresearch.com/report/pharmaceutical-contract-packaging-market/toc  

Key questions answered in the Pharmaceutical Contract Packaging Market are:

What are the upcoming industry applications and trends for the Pharmaceutical Contract Packaging Market?

What segments are covered in the Pharmaceutical Contract Packaging Market?

Who are the leading companies and what are their portfolios in Pharmaceutical Contract Packaging Market? 

What segments are covered in the Pharmaceutical Contract Packaging Market?

Who are the key players in the Pharmaceutical Contract Packaging Market?

Contact US : 

sales@straitsresearch.com    

Get More Related Press Release : 

https://www.femaleseniordating.com/blogs/9910/Ayurvedic-Toothpaste-Market-Expansion-Opportunities-and-Market-Dynamics-Through-2030

[neha24blog]

The market is primarily driven by growing awareness regarding health and hygiene, coupled with increased spending on pharmaceutical products, mainly in emerging economies. Moreover, many governments are focusing on strengthening pharmaceutical production facilities and population health management is further expanding the demand for pharmaceutical products, which results in boosting the market growth.

[sports9885]

India Pharmaceutical Glass Packaging Market

[industrynewsupdates]

Pharmaceutical Packaging Market Challenges, Strategies And Forecast Report 2024 - 2030

The global pharmaceutical packaging market size was valued at USD 139.37 billion in 2023 and is expected to grow a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030.

The enormous growth of the pharmaceutical sector is one of the primary growth factors for the pharmaceutical packaging sector. The pharmaceutical business has been expanding quickly in recent years due to scientific and technological advancements, and this trend is predicted to continue over the projection period, particularly in developing nations like China, India, Saudi Arabia, and Brazil.

The U.S. accounted for the largest pharmaceutical market worldwide. Large healthcare system, high per capita income, and large investments in drug development in the country are some of the key factors driving the U.S. market. Furthermore, growing importance of generic drugs and access to better healthcare services are anticipated to provide lucrative opportunities for pharmaceutical packaging in the coming years. The 21st Century Cures Act (Cures Act) was signed on December 13, 2016, in the U.S. and is designed to accelerate medical product development. The law is expected to drive new innovations in product developments in pharmaceutical industry. This is expected to drive the demand for pharmaceutical packaging in U.S.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Packaging Market

Pharmaceutical Packaging Market Report Highlights

• Asia Pacific is expected to register the fastest CAGR of more than 12% from 2024 to 2030. This growth is due to the rapidly expanding pharmaceutical market, particularly in China & India, and rising cases of various diseases, such as cancer and heart problems

• In terms of material, the glass segment is projected to ascend at the highest CAGR of 10.3% over the forecast period. Strong chemical resistance to various medicinal products and the ability to withstand heating treatment during the sterilization process is expected to expand the penetration of glass packaging

• Pharma manufacturing is the key end-use segment that accounted for the highest share of 49.9% in 2023 and is expected to witness strong growth from 2024 to 2030. This is owing to the increasing demand for medicines.

• In April 2022, Amcor has launched new and more sustainable High Shield laminates to its pharmaceutical packaging portfolio. This is low carbon, recycle-ready, and moisture resistant packaging solution, thus end use companies’ recyclability agendas

Browse through Grand View Research's Plastics, Polymers & Resins Industry Research Reports.

• The global flexible paper packaging market size was estimated at USD 50.35 billion in 2023 and is projected to grow at a CAGR of 4.2% from 2024 to 2030. 

• The global seaweed packaging market size was valued at USD 699.23 million in 2023 and is expected to expand at a CAGR of 6.6% from 2024 to 2030.

Pharmaceutical Packaging Market Segmentation

Grand View Research has segmented the pharmaceutical packaging market on the basis of on material, product, drug delivery mode, end-use, and region:

Pharmaceutical Packaging Material Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Plastics & Polymers

o Polyvinyl Chloride (PVC)

o Polypropylene (PP)

o Homo

o Random

o Polyethylene Terephthalate (PET)

o Polyethylene (PE)

o HDPE

o LDPE

o LLDPE

o Polystyrene (PS)

o Others

• Paper & Paperboard

• Glass

• Aluminium Foil

• Others

Pharmaceutical Packaging Product Outlook (Revenue, USD Million, 2018 - 2030)

• Primary

o Plastic Bottles

o Caps & Closures

o Parenteral Containers

o Syringes

o Vials & Ampoules

o Others

o Blister Packs

o Prefillable Inhalers

o Pouches

o Medication Tubes

o Others

• Secondary

o Prescription Containers

o Pharmaceutical Packaging Accessories

• Tertiary

Pharmaceutical Packaging Drug Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Oral Drugs

• Injectables

• Topical

• Ocular/ Ophthalmic

• Nasal

• Pulmonary

• Transdermal

• IV Drugs

• Others

Pharmaceutical Packaging End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharma Manufacturing

• Contract Packaging

• Retail Pharmacy

• Institutional Pharmacy

Pharmaceutical Packaging Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o UK

o France

o Italy

o Spain

o Russia

o Turkey

• Asia Pacific

o China

o India

o Japan

o South Korea

o Australia

o Southeast Asia

• Central & South America

o Brazil

o Argentina

• Middle East & Africa

o Saudi Arabia

o UAE

o South Africa

o Egypt

Order a free sample PDF of the Pharmaceutical Packaging Market Intelligence Study, published by Grand View Research.

[pearlsmith25]

Anti-counterfeit Pharmaceutical Packaging Market: Key Strategies for Drug Authentication

The pharmaceutical industry plays a critical role in public health by providing life-saving medications and treatments. However, this industry faces an ongoing challenge: counterfeit drugs. Counterfeit pharmaceuticals pose a significant threat to patients' health, as they may contain ineffective or harmful ingredients. To combat this issue, the pharmaceutical sector has embraced anti-counterfeit pharmaceutical packaging solutions. In this article, we will delve into the "Anti-counterfeit Pharmaceutical Packaging Market," exploring its growth drivers, current trends, key players, and future prospects.

The Need for Anti-counterfeit Pharmaceutical Packaging

Counterfeit pharmaceuticals are a global concern, with potentially devastating consequences. Patients relying on counterfeit drugs may experience worsened health conditions, adverse side effects, or even fatalities. The World Health Organization (WHO) estimates that around 10% of drugs available worldwide are counterfeit, with the percentage rising in some regions. To address this alarming issue, the pharmaceutical industry has adopted anti-counterfeit measures, and packaging is at the forefront of these efforts.

Market Growth Drivers

Stringent Regulatory Requirements: Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have implemented strict guidelines regarding pharmaceutical packaging and labeling to ensure product integrity and patient safety. Compliance with these regulations drives the adoption of anti-counterfeit packaging solutions market.

Increasing Counterfeit Drug Incidents: As counterfeit drug incidents continue to rise, pharmaceutical companies are compelled to invest in advanced packaging technologies to protect their brand reputation and, more importantly, patient well-being.

Advancements in Technology: Innovations in printing, tracking, and authentication technologies have made it easier for pharmaceutical companies to implement anti-counterfeit measures in their packaging. QR codes, holograms, tamper-evident seals, and unique serial numbers are just a few examples of such advancements.

Growing Pharmaceutical Industry: The pharmaceutical industry is expanding, driven by an aging population, increased healthcare spending, and the demand for new treatments. This growth, in turn, fuels the demand for effective anti-counterfeit packaging solutions.

Current Trends in the Market

Track-and-Trace Technologies: Pharmaceutical companies are increasingly adopting track-and-trace technologies to monitor the movement of their products throughout the supply chain. This ensures that medications reach their intended destination without tampering.

Smart Packaging: Smart packaging solutions, such as RFID (Radio-Frequency Identification) tags and NFC (Near-Field Communication) labels, enable real-time monitoring of products and enhance supply chain security.

Authentication Features: Innovative authentication features, like digital watermarks and 3D holograms, are being integrated into pharmaceutical packaging to make it more difficult for counterfeiters to replicate.

Blockchain in Pharmaceuticals: Blockchain technology is gaining traction in the pharmaceutical industry to create transparent and immutable records of a drug's journey from manufacturer to consumer. This helps in verifying the authenticity of pharmaceutical products.

Key Players in the Market

Several companies specialize in providing anti-counterfeit pharmaceutical packaging solutions. Some of the key players in this market include:

Avery Dennison Corporation: Known for its expertise in labeling and packaging materials, Avery Dennison offers a range of anti-counterfeit solutions, including tamper-evident labels and RFID tags.

CCL Industries Inc.: CCL Industries is a global leader in specialty packaging solutions, offering technologies such as brand protection labels and tamper-evident closures.

SICPA: SICPA specializes in secure traceability and authentication solutions, providing pharmaceutical companies with tools to combat counterfeit drugs effectively.

Essentra: Essentra focuses on providing packaging, authentication, and security solutions tailored to the pharmaceutical industry's needs.

Future Prospects

The anti-counterfeit pharmaceutical packaging market is poised for significant growth in the coming years. As the pharmaceutical industry expands and regulations become even more stringent, the demand for innovative packaging solutions will continue to rise. Furthermore, advancements in technology, including the integration of blockchain and artificial intelligence, will further enhance the effectiveness of anti-counterfeit measures.

In conclusion, the "Anti-counterfeit Pharmaceutical Packaging Market Growth" is essential for safeguarding public health and maintaining the integrity of the pharmaceutical industry. As counterfeit drug incidents persist, pharmaceutical companies will increasingly invest in advanced packaging solutions to protect their products and, most importantly, their patients. With evolving technology and a commitment to regulatory compliance, this market is set to play a pivotal role in ensuring the safety and efficacy of pharmaceutical products in the years to come.

[poojascmi]

India Pharmaceutical Packaging Market Is Estimated To Witness High Growth Owing To Increasing Demand for Safe Drug Packaging

The India Pharmaceutical Packaging Market is estimated to be valued at USD 1,573.40 million in 2021 and is expected to exhibit a CAGR of 7.50% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: The India Pharmaceutical Packaging Market refers to the packaging solutions specifically designed for pharmaceutical products. These packaging solutions ensure the safety, integrity, and efficacy of the drugs during storage, transportation, and distribution. The need for pharmaceutical packaging arises from the requirement to protect the drugs from moisture, light, oxygen, and other external factors that can potentially degrade their quality. Additionally, pharmaceutical packaging also plays a crucial role in providing important information such as dosage instructions, expiry dates, and batch numbers to the end-users. B) Market Key Trends: One key trend driving the growth of the India Pharmaceutical Packaging Market is the increasing demand for safe drug packaging. With the rising prevalence of counterfeit drugs in the market, there is a growing concern among consumers regarding the safety and authenticity of the drugs they purchase. As a result, pharmaceutical companies are focusing on implementing advanced packaging solutions that incorporate tamper-evidence features and anti-counterfeiting technologies. For example, blister packs with holographic seals and track-and-trace systems are being widely adopted to ensure the integrity of drugs and prevent counterfeiting. C) PEST Analysis: Political: The Indian government has implemented strict regulations and guidelines for pharmaceutical packaging to ensure the safety of drugs and protect consumer interests. Economic: The pharmaceutical industry in India is witnessing substantial growth due to factors such as increasing healthcare expenditure, a large patient population, and favorable government initiatives. Social: There is a growing awareness among consumers regarding the importance of safe drug packaging and its impact on health outcomes. Technological: The pharmaceutical packaging industry in India is witnessing advancements in technologies such as smart packaging, RFID tagging, and serialization, which help improve the efficiency and traceability of drugs. D) Key Takeaways: - The India Pharmaceutical Packaging Market Size is expected to witness high growth, exhibiting a CAGR of 7.50% over the forecast period, due to increasing demand for safe drug packaging. - The fastest growing and dominating region in the India Pharmaceutical Packaging Market is North India, which is home to several pharmaceutical manufacturing hubs and healthcare facilities. - Key players operating in the India Pharmaceutical Packaging Market are Amcor Plc, Aptar Group Inc., Huhtamaki Plc, and Uflex Limited. These companies are focusing on product innovation, strategic partnerships, and acquisitions to expand their market share. In conclusion, the India Pharmaceutical Packaging Market is experiencing significant growth due to the increasing demand for safe drug packaging. The market is driven by the need to protect drugs from external factors and prevent counterfeiting. With advancements in technology and stringent government regulations, the market is expected to flourish in the coming years. The key players in the market are actively investing in research and development to stay competitive in this evolving landscape.